Table 5.
Multivariate predictors of ASQ total—clinical sample
| Covariate | Clinical | |||
| β estimate | SE | Wald χ2 | P value | |
| Diagnosis (vs healthy control) | 711.8 | <0.0001 | ||
| GAD | 5.1 | 0.51 | 100.3 | <0.0001 |
| SAD | 4.5 | 0.47 | 92 | <0.0001 |
| Panic | 5.2 | 0.56 | 85.9 | <0.0001 |
| MDD | 2.8 | 0.59 | 21.9 | <0.0001 |
| Gender (F vs M) | 0.4 | 0.23 | 3.9 | 0.049 |
| Age (years) | –0.04 | 0.0079 | 22.3 | <0.0001 |
| Comorbidity (Y vs N) | 0.5 | 0.27 | 3.68 | 0.055 |
| MADRS total | 1.3 | 0.076 | 99.8 | <0.0001 |
| BDI total | – | – | – | – |
ASQ, Anxiety Symptoms Questionnaire; BDI, Beck Depression Inventory; F, female; GAD, generalised anxiety disorder; M, male; MADRS, Montgomery Asberg Depression Ratting Scale; MDD, major depressive disorder; N, no; Y, yes.